Home » Market News » DirectorsTalk Highlights » Nut allergy woman returns to Essex home after five years
Allergy therapeutics plc

Nut allergy woman returns to Essex home after five years

A woman who suffered a severe allergic reaction to nuts during a holiday to Hungary has returned to her family home after five years in care.

Amy May Shead, 31, suffered anaphylactic shock from a single bite of a chicken meal during a trip with friends to Budapest in 2014.

She will now receive 24-hour care in a specially-adapted annex of her parents’ home in Westcliff-on-Sea, Essex.

Allergy Therapeutics (LON:AGY) is an international commercial biotechnology group focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional fourteen countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.